TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging USA - English APAC - Traditional Chinese USA - English Japan - Japanese USA - Français
The Californer/10291759

Trending...
~ TVM Capital Healthcare, a renowned international healthcare expansion and growth capital firm, has recently made a significant equity investment in Human Longevity, Inc. (HLI), a San Francisco-based company that has been at the forefront of advancing precision medicine for healthy aging since 2013. This investment will not only support HLI's growth in the United States but also facilitate its expansion into the Kingdom of Saudi Arabia and Southeast Asia.

Founded by Dr. J. Craig Venter, a pioneer in human genome sequencing, HLI is driven by his vision for a longer and healthier life through the democratization of genomics. The company is widely recognized as a leader in the rapidly expanding field of longevity medicine due to its expertise in genomics and other areas of precision medicine such as imaging. It boasts an unparalleled longitudinal patient dataset built on decades of research, making it a valuable resource for detecting gene-disease associations. HLI's proprietary tools, including an artificial intelligence health risk and recommendation platform, enable pre-symptomatic diagnosis and customized treatments to preempt diseases at an early stage and maximize health outcomes. In essence, HLI is transforming healthcare from reactive to predictive, proactive, and preventative, not only improving individual lives but also enhancing the efficiency and effectiveness of the entire healthcare system.

More on The Californer
TVM Capital Healthcare brings extensive global investment experience along with operational expertise in the Middle East and Southeast Asia to this partnership. The firm has a proven track record of building innovative healthcare companies and will support HLI's expansion through its investment from the Saudi Arabia-focused TVM Healthcare Afiyah Fund LP - the largest growth capital fund of its kind in the region - which closed earlier this year. Initially focusing on market entry in Saudi Arabia, TVM Capital Healthcare aims to support HLI's growth as part of the country's Vision 2030 and Health Sector Transformation Program that prioritize preventive care over "sick care." These initiatives target critical fields such as oncology, neurology, metabolic syndrome, diabetes, cardiovascular and autoimmune diseases. The Saudi government has also shown a keen interest in longevity science, with investments in projects and companies in this field through initiatives like the Saudi Human Genome Program and the Hevolution Foundation.

Dr. J. Craig Venter, Co-Founder and Chief Scientific Advisor of HLI, expressed his excitement about the investment from TVM Capital Healthcare, stating that it will strengthen the company's position as a global leader in data-backed longevity medicine. He believes that their approach to preventive medicine has the potential to save millions of lives and significantly reduce healthcare costs in the future. Dr. Helmut M. Schuehsler, Chairman and CEO of TVM Capital Healthcare, also shared his enthusiasm for this partnership, emphasizing their contribution to the transition towards "healthcare of the future" that focuses on precision medicine, personalized care, and disease prevention.

More on The Californer
Dr. Ghida Harfouche, Partner at TVM Capital Healthcare, highlighted HLI's cutting-edge science that enables precision medicine for disease prevention and highly personalized interventions for clients. She expressed her pleasure in supporting HLI's global growth and working towards democratizing healthy longevity and preventative care.

TVM Capital Healthcare is widely recognized as the first international healthcare fund manager investing in and operating healthcare companies in Saudi Arabia. The firm is also active across the wider Middle East and Southeast Asia regions. In addition to supporting healthcare growth companies from Europe and the U.S., TVM Capital Healthcare also invests in leading local companies to improve access to world-leading products, technologies, and services across its target markets.

In conclusion, this investment by TVM Capital Healthcare marks a significant milestone for HLI's expansion plans into new markets while also contributing to the advancement of precision medicine globally. With their combined expertise and resources, both companies are poised to make a significant impact on society by promoting preventive care and improving access to cutting-edge healthcare solutions.
Filed Under: Business
Show All News | Report Violation

0 Comments

Latest on The Californer